Purchase Short-Term Access

Is It Safe to Conclude that Beers Criteria Medications Led to Few Adverse Events?
Adam Golden, MD, MBA; Mark H. Beers, MD; Donna M. Fick, RN, PhD
Annals of Internal Medicine 2008;148:628-629. doi:10.7326/0003-4819-148-8-200804150-00017

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.